4D Molecular Therapeutics (FDMT) Other Gross PP&E Adjustments (2019 - 2025)
4D Molecular Therapeutics (FDMT) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $15.3 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 23.96% to $15.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.3 million through Dec 2025, up 23.96% year-over-year, with the annual reading at $15.3 million for FY2025, 23.96% up from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was $15.3 million at 4D Molecular Therapeutics, up from $13.1 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $20.4 million in Q2 2024, with the low at $3.6 million in Q4 2021.
- Average Other Gross PP&E Adjustments over 5 years is $13.6 million, with a median of $13.4 million recorded in 2025.
- The sharpest move saw Other Gross PP&E Adjustments surged 331.75% in 2022, then crashed 35.68% in 2024.
- Over 5 years, Other Gross PP&E Adjustments stood at $3.6 million in 2021, then surged by 331.75% to $15.5 million in 2022, then rose by 22.49% to $18.9 million in 2023, then plummeted by 34.67% to $12.4 million in 2024, then grew by 23.96% to $15.3 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $15.3 million, $13.1 million, and $13.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.